Navigation Links
Central Mississippi Steel Magnolias Affiliate of Susan G. Komen for the Cure, Legislators, Health Officials, Breast Cancer Survivors and Activists Call for Action on Breast Cancer
Date:11/7/2007

Mississippi Joins Nationwide Campaign Challenging U.S. to Close the Gaps in

Breast Cancer Care, Survival

JACKSON, Miss., Nov. 7 /PRNewswire/ -- On Tuesday, Nov. 13, the Central Mississippi Steel Magnolias Affiliate of Susan G. Komen for the Cure will host a public forum to launch the state's participation in the Komen Community Challenge. The Mississippi Community Challenge events mark the fifteenth stop of a 25-city campaign to elevate breast cancer on the national agenda and to draw attention to disparities in breast cancer mortality.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

Health care providers, advocates, breast cancer survivors and elected officials will gather at the UMC Conference Center to discuss how to close the gaps in research, public policy and access to quality care that make breast cancer deadlier for some women. In addition, a powerful Komen video documentary, I Don't Want To Know, featuring Madison County patients and doctors who movingly illustrate the barriers to care facing too many Mississippi women, will be aired.

Nationwide, one in eight women will get breast cancer in her lifetime. Many Americans -- racial and ethnic minorities, low income women and those with little or no health insurance -- are less likely to receive quality cancer care and are more likely to die from the disease. Mississippi has the 3rd highest breast cancer mortality rate in the nation. More than 1,600 Mississippi women are diagnosed every year, and 450 will die from the disease.

WHAT: "Close The Gap" Public Forum on Breast Cancer

WHO: Paul Ott, Forum Moderator, Talk Show Host-Listen to the Eagle, &

breast cancer survivor

Senator Alan Nunnelee, Tupelo, Chair of Public Health & Welfare

Committee

Representative John Hines, Greenville, Member of Public Health &

Welfare Committee

Dr. Ralph Vance, Oncologist, Former National President of American

Cancer Society

Dr. Phillip Ley, Surgical Oncologist, Mississippi Breast Center

Dr. Annette Low, Director of Center of Excellence in Women's

Health, University of MS Medical Center

Dr. Ed Thompson, Interim Director of MS State Health Department

Melody Fortune, Executive Director of State Breast & Cervical

Cancer Early Detection Program

Karen Livingston-Wilson, Attorney/Partner at Butler|Snow Law Firm,

Komen Steele Magnolia Affiliate Grant Chair & breast cancer

survivor

Dr. Cheryl Perkins, Senior Clinical Advisor for Susan G. Komen for

the Cure, native Mississippian & breast cancer survivor

WHEN: Tuesday, November 13, 9:00 - 11:30 am

WHERE: UMC Conference Center at the Jackson Medical Mall

350 W. Woodrow Wilson Drive (Livingston Street entrance)

Jackson, MS


'/>"/>
SOURCE Susan G. Komen for the Cure
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain
2. HealthCentral.com Launches Greeting Card Application on Facebook.com
3. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
4. Community Leaders to Host Press Event at L.A. Central Jail Urging Governor to Sign AB 1334
5. Aegis Selected by Community Medical Centers to Bring New Employer-Focused Wellness Program to Californias Central Valley
6. New England Journal of Medicine Selects ScholarOnes Manuscript Central for Online Peer Review
7. Omnicell Introduces the Next Generation Central Pharmacy Automation Solution
8. The HealthCentral Network Announces Participation in the Launch of Microsoft HealthVault
9. Illinois Planning Board Approves Central DuPage Hospital Bed Pavilion
10. Biotech adds Central American markets to Sucanon distribution
11. Halloween Events in Central Valley, Calif. Bring Young and Old Together for a Ghoulish Good Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging ... Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, ...
(Date:12/5/2016)... ... 2016 , ... A newly released study has found that ... accuracy of placing precordial electrodes with little cognitive effort and a high degree ... studies have shown that single electrode misplacement is one of the single largest ...
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 03, 2016 , ... While James Earl Jones is known for myriad roles ... show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a very ... in large part due to early detection. Like any other disease, treatments have a ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® was ... Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and ... Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec 5, 2016 Research and Markets ... Market - Global Forecast to 2021" report to their offering. ... , , ... reach 17.27 billion by 2021, at a CAGR of 5.3% from 2016 ... growing number of obesity cases, increasing government spending on healthcare, and rising ...
(Date:12/5/2016)... PharmaBoardroom today releases its new 70 page Switzerland Healthcare & Life ... , , ... stakeholders crucial insight into Switzerland ; a country located ... of the world,s most important international health institutions as well as two ... number one ranking globally in terms of ease of doing business and ...
(Date:12/4/2016)... , Dec. 4, 2016 Blueprint ... in discovering and developing targeted kinase medicines for ... from its ongoing Phase 1 trial evaluating BLU-285, ... with advanced systemic mastocytosis (SM). Blueprint Medicines is ... of D816V mutant KIT. Approximately 90 to 95 ...
Breaking Medicine Technology: